Covid-19 Passport Moves Into Trial Phase
COVID-19 immunity & vaccine passport from iProov & Mvine moves into trial phase with NHS.
Mvine and iProov announced today their design for a simple recognised Covid-19 immunity and vaccination passport will now move into live testing.
The Mvine-iProov passport enables a person’s test result or vaccination status to be registered but leaves their identity anonymous.
Directors of Public Health within the National Health Service (NHS) will now test the design by running two trials by 31 March 2021.
The new passport can be plugged into the NHS’ existing infrastructure, enabling it to meet the specific needs of local Directors of Public Health.
By crucially using the new design in the NHS it ensures that areas in different tiers or levels of vaccination roll out can set appropriate policies and enforce them with confidence.
The investment may help employees return to work and make reconnections with family happen more quickly and more responsibly than would otherwise be possible.
Frank Joshi, Director at Mvine, said: “Unlike some other digital solutions for Covid-19, this technology reduces the burden on frontline services”
“It cost-effectively assures a secure and safe way to enable the return to work, return to school and return to the kind of life that people want to lead.”